Balyasny Asset Management L.P. Invests $5.57 Million in Henry Schein, Inc. (NASDAQ:HSIC)

Balyasny Asset Management L.P. purchased a new position in Henry Schein, Inc. (NASDAQ:HSIC - Free Report) during the 4th quarter, according to its most recent 13F filing with the SEC. The firm purchased 80,425 shares of the company's stock, valued at approximately $5,565,000. Balyasny Asset Management L.P. owned about 0.06% of Henry Schein as of its most recent SEC filing.

Other hedge funds and other institutional investors have also made changes to their positions in the company. Barclays PLC lifted its holdings in Henry Schein by 6.9% during the third quarter. Barclays PLC now owns 286,475 shares of the company's stock worth $20,882,000 after acquiring an additional 18,458 shares in the last quarter. Franklin Resources Inc. lifted its holdings in Henry Schein by 14.0% during the third quarter. Franklin Resources Inc. now owns 37,637 shares of the company's stock worth $2,673,000 after acquiring an additional 4,621 shares in the last quarter. Principal Financial Group Inc. lifted its holdings in Henry Schein by 2.1% during the third quarter. Principal Financial Group Inc. now owns 145,835 shares of the company's stock worth $10,631,000 after acquiring an additional 3,037 shares in the last quarter. Nordea Investment Management AB lifted its holdings in Henry Schein by 8.6% during the fourth quarter. Nordea Investment Management AB now owns 10,974 shares of the company's stock worth $761,000 after acquiring an additional 869 shares in the last quarter. Finally, Czech National Bank raised its stake in shares of Henry Schein by 4.7% in the 4th quarter. Czech National Bank now owns 27,034 shares of the company's stock valued at $1,871,000 after purchasing an additional 1,223 shares during the period. 96.62% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

A number of analysts recently issued reports on HSIC shares. Piper Sandler lowered their target price on Henry Schein from $83.00 to $77.00 and set an "overweight" rating on the stock in a research report on Wednesday, April 30th. StockNews.com downgraded Henry Schein from a "buy" rating to a "hold" rating in a research report on Thursday, April 17th. Wells Fargo & Company lowered their price target on Henry Schein from $80.00 to $75.00 and set an "equal weight" rating on the stock in a research report on Tuesday, May 6th. Barrington Research lowered their price target on Henry Schein from $90.00 to $86.00 and set an "outperform" rating on the stock in a research report on Tuesday, May 6th. Finally, UBS Group lowered their price target on Henry Schein from $83.00 to $80.00 and set a "neutral" rating on the stock in a research report on Wednesday, February 26th. Six equities research analysts have rated the stock with a hold rating, five have given a buy rating and one has given a strong buy rating to the company. According to MarketBeat.com, the company presently has an average rating of "Moderate Buy" and a consensus target price of $79.30.

Henry Schein Stock Performance

Shares of NASDAQ:HSIC traded down $0.46 during trading on Wednesday, reaching $70.08. 1,568,384 shares of the stock were exchanged, compared to its average volume of 1,640,455. The company has a current ratio of 1.42, a quick ratio of 0.82 and a debt-to-equity ratio of 0.46. The firm has a market cap of $8.53 billion, a PE ratio of 28.84, a PEG ratio of 2.13 and a beta of 0.87. The stock has a 50-day moving average price of $67.52 and a 200-day moving average price of $71.45. Henry Schein, Inc. has a 12 month low of $60.56 and a 12 month high of $82.49.

Henry Schein (NASDAQ:HSIC - Get Free Report) last announced its quarterly earnings data on Monday, May 5th. The company reported $1.15 EPS for the quarter, beating the consensus estimate of $1.11 by $0.04. Henry Schein had a net margin of 2.51% and a return on equity of 12.90%. The business had revenue of $3.17 billion during the quarter, compared to the consensus estimate of $3.24 billion. During the same period in the previous year, the business earned $1.10 earnings per share. The company's revenue was down .1% on a year-over-year basis. Research analysts expect that Henry Schein, Inc. will post 4.74 EPS for the current fiscal year.

Insider Activity at Henry Schein

In other Henry Schein news, CEO Bradford C. Connett sold 4,036 shares of the stock in a transaction dated Wednesday, March 19th. The stock was sold at an average price of $71.15, for a total transaction of $287,161.40. Following the completion of the sale, the chief executive officer now directly owns 62,688 shares in the company, valued at approximately $4,460,251.20. This trade represents a 6.05% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, Director Philip A. Laskawy sold 2,604 shares of the stock in a transaction dated Wednesday, March 19th. The stock was sold at an average price of $71.04, for a total value of $184,988.16. Following the sale, the director now owns 24,805 shares of the company's stock, valued at approximately $1,762,147.20. The trade was a 9.50% decrease in their ownership of the stock. The disclosure for this sale can be found here. 1.08% of the stock is currently owned by company insiders.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.